Perspectives in Medical Research

References

1. Alexander T, Mehta S, Mullasari A, Nallamothu B K. Systems of care for ST-elevation myocardial infarction in India. Heart. 2012 Jan; 98:15-7
2. Sharma M, Ganguly NK. Premature coronary artery disease in Indians and its associated risk factors. Vasc Health Risk Manag. 2005; 1:217-25.
3. Chauhan S, Aeri BT. Prevalence of cardiovascular disease in India and it is economic impact- A review. International Journal of Scientific and Research Publications, 2013;3 (10)
4. Ghaffar A, Reddy KS, Singhi M. Burden of noncommunicable diseases in South Asia. BMJ 2004; 10: 328:807.
5. JeemonP , Reddy KS. Social determinants of cardiovascular disease outcomes in Indians. Indian J Med Res. 2010;132: 617-622
6. Xavier D, Pais P, Devereaux PJ et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet. 2008; 371:1435-42.
7. Steg PG , James SK, Atar D et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012: 33: 2569-619.
8. Stone GW, Angioplasty Strategies in ST-Segment– Elevation Myocardial Infarction. Part I: Primary Percutaneous Coronary Intervention - Circulation 2008; 118: 538–51.
9. Victor SM, Subban V, Alexander T. A prospective, observational, multicentre study comparing tenecteplase facilitated PCI versus primary PCI in Indian patients with STEMI (STEPP—AMI). Open Heart. 2014; 1(1): e000133.
10. Larson MD, Duval S, Sharkey WS et al. Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural STelevation myocardial infarction patients with expected delays due to long-distance transfers. Eur Heart J 2012; 33:1232-40.
11. Chandra P. Coronary and non-coronary intervention data. Presented at the Interventional Council of India Midterm Annual Meeting 2014 - Kochi
12. Iyengar SS, Nair T, Sathyamurthy I. Efficacy and safety of tenecteplase in ST elevation myocardial infarction patients from the Elaxim Indian Registry. Indian Heart J. 2009;61:480-1.
13. Antman EM, Anbe DT, Armstrong PW et al. ACC/AHA guidelines for the management of patients with STelevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction).J Am CollCardiol. 2004 Aug 4; 44(3):E1-E211.
14. Nallamothu BK, Bates ER. - Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol. 2003; 92(7):824-6.
15. Fernández-Avilés F, Alonso JJ, Peña G, et al. Primary angioplasty vs.early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. Eur Heart J. 2007; 28(8):949-60